{"id":"structured-treatment-interruptions","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Immune reconstitution inflammatory syndrome"},{"rate":"5-10%","effect":"Resurgence of HIV-1"},{"rate":"5-10%","effect":"Other opportunistic infections"}]},"_chembl":{"chemblId":"CHEMBL7257","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This approach allows researchers to evaluate the effectiveness of the immune system in suppressing the virus, providing valuable insights into the disease's progression and the potential for long-term remission. By temporarily interrupting treatment, the body's natural defenses can be observed, and the impact of antiretroviral therapy on the immune system can be better understood.","oneSentence":"Structured Treatment Interruptions involve temporarily stopping antiretroviral therapy to assess the body's natural ability to control HIV.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:32.592Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection"}]},"trialDetails":[{"nctId":"NCT00021762","phase":"PHASE2","title":"Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00050089","phase":"NA","title":"CSP #512 - Options in Management With Anti-Retrovirals","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2001-01","conditions":"AIDS, HIV Infections","enrollment":368},{"nctId":"NCT00100646","phase":"NA","title":"Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa","status":"COMPLETED","sponsor":"The Wistar Institute","startDate":"2007-03","conditions":"HIV Infections","enrollment":30},{"nctId":"NCT00084032","phase":"NA","title":"Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00820118","phase":"PHASE2","title":"Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2009-05","conditions":"HIV Infections","enrollment":45},{"nctId":"NCT01293513","phase":"NA","title":"Structured Treatment Interruption (STI) in Acute/Primary HIV","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2011-02","conditions":"HIV Infections","enrollment":10},{"nctId":"NCT00001948","phase":"","title":"A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"1999-12","conditions":"HIV Infection","enrollment":70},{"nctId":"NCT00310245","phase":"PHASE3","title":"BASTA Study on STI in HIV Infected Patients","status":"COMPLETED","sponsor":"A.O. Ospedale Papa Giovanni XXIII","startDate":"2000-11","conditions":"HIV Infection","enrollment":130},{"nctId":"NCT00324103","phase":"PHASE3","title":"Structured Treatment Interruptions in Chronic HIV Infection","status":"COMPLETED","sponsor":"Istituto Superiore di Sanità","startDate":"2001-06","conditions":"HIV Infection","enrollment":600},{"nctId":"NCT00125814","phase":"PHASE3","title":"Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression","status":"TERMINATED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2001-12","conditions":"HIV Infections","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":128,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Structured Treatment Interruptions","genericName":"Structured Treatment Interruptions","companyName":"Istituto Superiore di Sanità","companyId":"istituto-superiore-di-sanit","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Structured Treatment Interruptions involve temporarily stopping antiretroviral therapy to assess the body's natural ability to control HIV. Used for HIV-1 infection.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}